CIK 0000868278 · Non-accelerated filer<br>Smaller reporting company
ProPhase Labs, Inc.
Sign in to watch- Ticker
- PRPH
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 232577138
- Phone
- (215) 345-0919
- Business address
- 711 STEWART AVE, SUITE 200, GARDEN CITY, NEW YORK, NY, 11530
- Former names
- QUIGLEY CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 99 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-12-19 | Karkus Ted William CEO & Chairman | Grant or award · Option (right to buy) | +100,000 | 100,000 | ||
| 2013-12-19 | CUDDIHY ROBERT V JR COO / CFO | Grant or award · Option (right to buy) | +120,000 | 120,000 | ||
| 2013-07-15 | MCCUBBIN JAMES T Director | Grant or award | +2,745 | 28,682 | ||
| 2013-07-15 | Burnett Mark A. Director | Grant or award | +2,745 | 304,513 | ||
| 2013-07-15 | Frank Mark Shawn Director | Grant or award | +2,745 | 72,940 | ||
| 2013-06-25 | Karkus Ted William CEO & Chairman | Purchase | +155,480 | $1.58 | $246K | 2,164,588 |
| 2013-06-24 | Karkus Ted William CEO & Chairman | Purchase | +286,150 | $1.56 | $446K | 2,009,108 |
| 2013-06-23 | Karkus Ted William CEO & Chairman | Purchase | +58,370 | $1.51 | $88K | 1,722,958 |
Page 8 of 8 · 148 trades